Joinn Labs of China Buys Bayer’s San Francisco-Area Campus
publication date: Jan 8, 2013
Joinn Laboratories, a pre-clinical CRO with facilities in Beijing and Taicang, bought the major biopharma campus in the San Francisco Bay area that formerly belonged to Bayer. Joinn, which was founded in 1995, is implementing a “go-big” strategy. It wants to offer major pharmaceutical companies the ability to work on several major projects simultaneously, minimizing the number of CRO contacts each pharma must maintain. Toward that end, Joinn is also building a 1.2 million square foot lab/office space in Taicang, in addition to its newly acquired facility in California
. More details....
Stock Symbol: (Xetra: BAY)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.